Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peribulbar Triamcinolone for Diabetic Macular Edema
NCT00231023Phase 2Completed
- Sponsor
- National Eye Institute
- Start
- Sep 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of triamcinolone acetonide in diabetic macular edema (DME), sponsored by National Eye Institute. Started Sep 2005; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00231023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00231023.